1210828-44-6Relevant articles and documents
Angiogenesis inhibitor as well as preparation method and application thereof
-
, (2021/02/13)
The invention belongs to the technical field of medicines, and discloses a compound shown as a formula I or pharmaceutically acceptable salt, prodrug, metabolite, isotope derivative and solvate thereof. The compound provided by the invention is a cyclobutyl-containing compound used as a tyrosine kinase inhibitor, and can be used for treating tyrosine kinase, especially tumor diseases related to VEGFR. Due to the existence of the cyclobutyl group, the rigidity of a branched chain molecule can be improved, the directivity of the molecule is improved, the compound can be better combined with a target easily, the dosage of a drug can be reduced, and the side effect of the drug is reduced. The invention also provides a preparation method of the compound and application of the compound in treatment of tumor diseases caused by abnormal activity of tyrosine kinase such as VEGFR.
Method for preparing anlotinib hydrochloride
-
Paragraph 0050-0052, (2019/05/28)
The invention discloses a method for preparing anlotinib hydrochloride. The method has the advantages that 7-benzyloxy-4-chlorine-6-methoxyquinoline compounds 1 and 1-(2-fluorine-3-hydroxyl-6-nitrophenyl) propyl-2-ketone compounds 2 are used as starting m
Compounds As Kinase Inhibitors
-
Page/Page column 14, (2010/03/31)
The present invention relates to compounds of Formula I, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of disease states associated with angiogenesis, such as cancers associated with protein tyrosine kinases, to their use as medicaments for use in the production of inhibition of tyrosine kinases reducing effects in warm-blooded animals such as humans.